
OpenAI GPT Image 2 Launches, Shakes AI Landscape
OpenAI’s GPT Image 2 logged 500 million API requests in hours, immediately triggering market shifts like NVIDIA’s 4% dip and upending creative workflows with its ARM architecture.

OpenAI’s GPT Image 2 logged 500 million API requests in hours, immediately triggering market shifts like NVIDIA’s 4% dip and upending creative workflows with its ARM architecture.

A $25 billion investment solidifies Amazon’s AI alliance with Anthropic, guaranteeing the startup vast compute power for a decade while locking in Anthropic’s $100 billion commitment to AWS and Amazon’s custom AI chips.

As public data sources dry up, AI models are now being trained on the internal communications of defunct companies, raising significant ethical questions about employee privacy.

Strategic cuts to costly initiatives like Sora and the departure of key researchers signal OpenAI’s sharp focus on commercial viability.

The company is reorienting from costly experimental research to focus on enterprise solutions, profitability, and an upcoming public offering.

Once a Silicon Valley footwear favorite, Allbirds has entirely shed its brand, rebranding as NewBird AI to invest $50 million in high-performance AI compute infrastructure amidst a struggle for survival.

This powerful new reasoning model, developed after a major internal overhaul, marks a proprietary shift aimed at deep integration across the company’s product ecosystem.

This indictment reveals a sophisticated scheme to bypass U.S. export bans, escalating federal efforts to prevent China from acquiring advanced AI capabilities. It also raises serious questions about Super Micro’s corporate oversight.

The new platform leverages generative AI to translate scattered medical records and wearable metrics into a comprehensive health narrative. Backed by strict privacy controls and clinical guardrails, the tool aims to ease physician burnout while giving individuals deeper insight into their biology.
Applied machine learning, filed daily.
Model releases, silicon, clinical deployment, and the policy shaping them. No digest padding.